Hepatitis A among homosexual men and injection drug users: More evidence for vaccination

Clinical Infectious Diseases

Volumn 25, Issue 3, 1997, Pages 726-728

  Villano, Stephen A ^b   Nelson, Kenrad E ^b   Vlahov, David ^b   Purcell, Robert H ^b   Saah, Alfred J ^b   Thomas, David L ^a  

^a Division of Infectious Diseases   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADULT; ARTICLE; BLOOD DONOR; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS A; HIGH RISK PATIENT; HOMOSEXUALITY; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; VACCINATION; VIRUS TRANSMISSION;

EID: 0030881063     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/513757     Document Type: Article

References (13)

1. Hadler SC. Global impact of hepatitis A virus infection: changing patterns. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease: proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease: contemporary issues and future prospects. Baltimore: Williams & Wilkins, 1991;14-20.
2. Centers for Disease Control and Prevention. Hepatitis A among homosexual men - United States, Canada, and Australia. JAMA 1992;267:1587-8.
3. Henning KJ, Bell E, Braun J, Barker ND. A community-wide outbreak of hepatitis A: risk factors for infection among homosexual and bisexual men. Am J Med 1995;99:132-6.
4. Centers for Disease Control and Prevention. Hepatitis A among drug abusers. MMWR Morb Mortal Wkly Rep 1988;37:297-300, 305.
5. Centers for Disease Control and Prevention. Hepatitis surveillance report no. 55. Atlanta: Centers for Disease Control and Prevention, 1994:1.
6. Innis BL, Snitbhan R, Kunasol P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271:1328-34.
7. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. Journal of Drug Issues 1991;21:759-76.
8. Kaslow RA, Ostrow DG, Detels R, et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-8.
9. Azimi PH, Roberto RR, Guralnik J, et al. Transfusion-acquired hepatitis A in a premature infant with secondary nosocomial spread in an intensive care nursery. Am J Dis Child 1986;140:23-7.
10. Wong DC, Shapiro M, Purcell RH. Relative sensitivities of the intravenous and oral routes for infecting tamarins and chimpanzees with HAV [abstract A43]. In: 9th Triennial International Symposium on Viral Hepatitis and Liver Disease (Rome). 1996:66.
11. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users in Baltimore. Medicine (Baltimore) 1995;74:212-20.
12. Akriviadis EA, Redeker AG. Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann Intern Med 1989;110:838-9.
13. Keeffe EB. Clinical approach to viral hepatitis in homosexual men. Med Clin North Am 1986;70:567-86.